Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pratt

Showing results (291-300 of 325) with videos related to

Pageof 33
Sort By:
Research Involvement and Engagement|November 7, 2024
Patient and public involvement in the design of an international clinical trial: real world experienceGwenda Simons, Helen Jones, Ian Clarke, et al.
Frontiers in Medicine|March 11, 2022
Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA RegistryPaul Studenic, Aase Hensvold, Arnd Kleyer, et al.
Rheumatology (Oxford, England)|November 6, 2023
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacyDaniel Maunder, Philip M Brown, Ben Barron-Millar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2026
Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and healthJames A Stanway, Daniel Peters, Helen Waller, et al.
Clinical and Experimental Immunology|September 27, 2016
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4<sup>+</sup> T cells partly via transforming growth factor-β1A E Anderson, D J Swan, O Y Wong, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Genome Biology|November 2, 2016
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Amanda McGovern, Stefan Schoenfelder, Paul Martin, et al.
BMC Cancer|June 14, 2024
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort studyAbigail Gault, Linda Hogarth, Kristian C Williams, et al.
Hematological Oncology|October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvestsF E Davies, A C Rawstron, G Pratt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1996
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experienceM Barton, J Boyages, E Crennan, et al.
Pageof 33

Showing results (291-300 of 325) with videos related to

Sort By:
Pageof 33
Research Involvement and Engagement|November 7, 2024
Patient and public involvement in the design of an international clinical trial: real world experienceGwenda Simons, Helen Jones, Ian Clarke, et al.
Frontiers in Medicine|March 11, 2022
Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA RegistryPaul Studenic, Aase Hensvold, Arnd Kleyer, et al.
Rheumatology (Oxford, England)|November 6, 2023
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacyDaniel Maunder, Philip M Brown, Ben Barron-Millar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2026
Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and healthJames A Stanway, Daniel Peters, Helen Waller, et al.
Clinical and Experimental Immunology|September 27, 2016
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4<sup>+</sup> T cells partly via transforming growth factor-β1A E Anderson, D J Swan, O Y Wong, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Genome Biology|November 2, 2016
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Amanda McGovern, Stefan Schoenfelder, Paul Martin, et al.
BMC Cancer|June 14, 2024
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort studyAbigail Gault, Linda Hogarth, Kristian C Williams, et al.
Hematological Oncology|October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvestsF E Davies, A C Rawstron, G Pratt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1996
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experienceM Barton, J Boyages, E Crennan, et al.
Pageof 33